Milestone Scientific, Inc. Common Stock (MLSS) is a publicly traded Healthcare sector company. As of July 27, 2026, MLSS trades at $0.39 with a market cap of $34.51M and a P/E ratio of -5.57. MLSS moved +0.72% today. Year to date, MLSS is +42.62%; over the trailing twelve months it is -34.42%. Its 52-week range spans $0.22 to $1.39. Analyst consensus is buy with an average price target of $1.00. Rallies surfaces MLSS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Milestone Scientific Adds Shilling and Ulto to Board, Elevates Executive Chair: Milestone Scientific has appointed two independent directors, Greg Shilling and Kelly Ann Ulto, to its Board, adding expertise in healthcare technology, cybersecurity, audit and financial controls. The company also transitioned Benedetta I. Casamento to Executive Chair and restructured founder Len Osser’s advisory agreement to reinforce governance and strategic continuity.
| Metric | Value |
|---|---|
| Price | $0.39 |
| Market Cap | $34.51M |
| P/E Ratio | -5.57 |
| EPS | $-0.07 |
| Dividend Yield | 0.00% |
| 52-Week High | $1.39 |
| 52-Week Low | $0.22 |
| Volume | 2.14K |
| Avg Volume | 0 |
| Revenue (TTM) | $8.97M |
| Net Income | $-5.72M |
| Gross Margin | 71.40% |
1 analysts cover MLSS: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $1.00.